QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction

被引:26
作者
Krüger, S
Filzmaier, K
Graf, J
Kunz, D
Stickel, T
Hoffmann, R
Hanrath, P
Janssens, U
机构
[1] Univ Technol, Univ Hosp, Med Clin 1, Aachen, Germany
[2] Univ Technol, Univ Hosp, Inst Clin Chem & Pathobiochem, Aachen, Germany
关键词
brain natriuretic peptide; chronic heart failure; echocardiography; electrocardiography; left ventricular systolic dysfunction; QRS complex;
D O I
10.1046/j.1365-2796.2003.01265.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine whether the combination of prolonged QRS duration and brain natriuretic peptide (BNP) levels predicts left ventricular systolic dysfunction (LVSD) with a higher accuracy compared with QRS duration or BNP alone. Setting. University hospital. Methods. We studied 128 consecutive patients with suspected cardiac disease. At rest the QRS duration on 12-lead ECG and BNP levels were determined. A left ventricular ejection fraction (LVEF) <50% at echocardiography was defined as LVSD. Results. QRS duration in the LVSD group (n = 66, LVEF 30 +/- 8%) was longer than in the group without LVSD (n = 62, LVEF 60 +/- 5%; QRS 129 +/- 34 vs. 96 +/- 20 ms, P < 0.001). BNP was higher in the LVSD group compared with controls (467 +/- 397 vs. 169 +/- 242 pg mL(-1), P < 0.001). A QRS duration of >0.1, >0.11 or >0.12 s was highly specific (63, 90 and 98%) but less sensitive (84, 81 and 75%) for the prediction of LVSD. A QRS cut-off value of 106 ms was moderately sensitive (65%) but very specific (87%) for the prediction of LVSD, whereas a BNP cut-off value of >84 pg mL(-1) was highly sensitive (89%) but only modestly specific (58%). The positive likelihood ratio for LVSD of abnormal BNP (2.0) and QRS prolongation >0.1 s (2.3) was improved by the combination of both criteria (5.1). In multivariate analysis, BNP and QRS duration were independent predictors of LVSD. Conclusions. The combination of abnormal BNP and QRS prolongation yields a higher positive likelihood ratio for the detection of LVSD compared with the two criteria alone.
引用
收藏
页码:206 / 212
页数:7
相关论文
共 29 条
[1]   A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study [J].
Cheng, V ;
Kazanagra, R ;
Garcia, A ;
Lenert, L ;
Krishnaswamy, P ;
Gardetto, N ;
Clopton, P ;
Maisel, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :386-391
[2]  
COWIE MR, 1997, LANCET, V350, P1347
[3]   Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting [J].
Dao, Q ;
Krishnaswamy, P ;
Kazanegra, R ;
Harrison, A ;
Amirnovin, R ;
Lenert, L ;
Clopton, P ;
Alberto, J ;
Hlavin, P ;
Maisel, AS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :379-385
[4]   Prolonged QRS duration (ORS ≥ 170 ms) and left axis deviation in the presence of left bundle branch block:: A marker of poor left ventricular systolic function? [J].
Das, MK ;
Cheriparambil, K ;
Bedi, A ;
Kassotis, J ;
Reddy, CVR ;
Makan, M ;
Dunbar, CC ;
Saul, B .
AMERICAN HEART JOURNAL, 2001, 142 (05) :756-759
[5]  
DEVEREUX RB, 1987, HYPERTENSION, V9, P97
[6]  
Fischer Y, 2001, CLIN CHEM, V47, P591
[7]   COMPARISON OF NEUROENDOCRINE ACTIVATION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION WITH AND WITHOUT CONGESTIVE-HEART-FAILURE - A SUBSTUDY OF THE STUDIES OF LEFT-VENTRICULAR DYSFUNCTION (SOLVD) [J].
FRANCIS, GS ;
BENEDICT, C ;
JOHNSTONE, DE ;
KIRLIN, PC ;
NICKLAS, J ;
LIANG, CS ;
KUBO, SH ;
RUDINTORETSKY, E ;
YUSUF, S .
CIRCULATION, 1990, 82 (05) :1724-1729
[8]  
HAUG C, 1994, CLIN INVESTIGATOR, V72, P430
[9]   PLASMA-CONCENTRATION OF HUMAN BRAIN NATRIURETIC PEPTIDE IN PATIENTS ON HEMODIALYSIS [J].
ISHIZAKA, Y ;
YAMAMOTO, Y ;
FUKUNAGA, T ;
YOKOTA, N ;
KIDA, O ;
KITAMURA, K ;
KANGAWA, K ;
MINAMINO, N ;
MATSUO, H ;
ETO, T .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (03) :461-472
[10]   Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy [J].
Jensen-Urstad, K ;
Bouvier, F ;
Hojer, J ;
Ruiz, H ;
Hulting, J ;
Samad, B ;
Thorstrand, C ;
Jensen-Urstad, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (05) :538-544